Ticker

No recent analyst price targets found for MYCOF.

Latest News for MYCOF

Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000

Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") is pleased to announce its intention to complete a non-brokered private placement of convertible debentures of the Company (the "Debentures") in an aggregate principal amount of up to $500,000, issuable in increments of $1,000 principal amount, for…

Newsfile Corp • Aug 20, 2026
Noveris Health Sciences Receives USPTO Notice of Allowance, and Signs Work Order with API

Vancouver, British Columbia--(Newsfile Corp. - August 18, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) ("Noveris" or the "Company") is pleased to announce that the United States Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for the Company's U.S. Patent Application No. 18/443,025, titled "Aza-Substituted Psilocin Analogs and Methods of Synthesizing the Same.

Newsfile Corp • Aug 18, 2026
Noveris Health Sciences Inc. Unaware of Any Material Change

Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - At the request of CIRO, Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. Noveris is a Canadian life sciences company focused on…

Newsfile Corp • Aug 6, 2026
Noveris Health Sciences Joins BioAlberta

Vancouver, British Columbia--(Newsfile Corp. - July 30, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces that it has become a member of BioAlberta, a not-for-profit industry association representing Alberta's life sciences community. BioAlberta supports its members through industry development, educational and networking activities, and engagement…

Newsfile Corp • Jul 30, 2026
Noveris Health Sciences Joins the Biotechnology Innovation Organization (BIO)

VANCOUVER, BC, Canada – TheNewswire - July 17, 2026 — Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) (“Noveris” or the “Company”) is pleased to announce that it has joined the Biotechnology Innovation Organization (“BIO”), the world's largest advocacy association representing biotechnology companies, academic and research institutions, state and regional biotechnology centers and related…

TheNewswire • Jul 17, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for MYCOF.

No Senate trades found for MYCOF.

No House trades found for MYCOF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top